z-logo
Premium
Leptin correlates with monocytes activation and severe condition in COVID‐19 patients
Author(s) -
Wang Jingya,
Xu Yinyin,
Zhang Xiaoli,
Wang Sheng,
Peng Ziyi,
Guo Jing,
Jiang Hongmei,
Liu Jing,
Xie Ying,
Wang Jingjing,
Li Xin,
Liao Juan,
Wan Chao,
Yu Lihua,
Hu Jinsong,
Liu Beizhong,
Liu Zhiqiang
Publication year - 2021
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.5hi1020-704r
Subject(s) - biology , covid-19 , leptin , immunology , betacoronavirus , monocyte , coronavirus infections , virology , medicine , endocrinology , obesity , disease , infectious disease (medical specialty) , outbreak
Abstract Excessive monocyte activation with the development of excessive or uncontrolled release of proinflammatory cytokines often results in host tissue injury and even death in patients with pneumonia caused by the 2019 novel coronavirus. However, the changes of cytokine profiles of coronavirus disease 2019 (COVID‐19) patients, as well as the underlying mechanisms that are involved, remain unknown. Using a cytokine array containing 174 inflammation‐related cytokines, we found significantly altered cytokine profiles in severe COVID‐19 patients compared with those in mild patients or healthy controls, and identified leptin, CXCL‐10, IL‐6, IL‐10, IL‐12, and TNF‐α as the top differentially expressed cytokines. Notably, leptin showed high consistency with CXCL‐10 and TNF‐α in predicting disease severity, and correlated with body mass index, decreased lymphocyte counts, and disease progression. Further analysis demonstrated that monocytes in severe patients with higher leptin levels were inclined toward M1 polarization. Mechanistic studies revealed that leptin synergistically up‐regulated expression levels of inflammatory cytokines and surface markers with IL‐6 in monocytes through STAT3 and NF‐κB signaling pathways. Collectively, our results suggest that overweight COVID‐19 patients were prone to have higher leptin levels, which further activated monocytes, resulting in amplified or dysregulated immune responses. Taken together, our findings argue that leptin correlates severity of COVID‐19 and may indicate a possible mechanism by which overweight patients have a greater tendency to develop severe conditions.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here